HISTAMINE AS AN INTRACELLULAR MESSENGER

[1] BRANDES LJ, 1988, CANCER RES, V48, P3954

[2] A DIPHENYLMETHANE DERIVATIVE SELECTIVE FOR THE ANTI-ESTROGEN BINDING-SITE MAY HELP DEFINE ITS BIOLOGICAL ROLE [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 124 (01) : 244 - 249

[3] A DIPHENYLMETHANE DERIVATIVE SPECIFIC FOR THE ANTIESTROGEN BINDING-SITE FOUND IN RAT-LIVER MICROSOMES [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 123 (02) : 724 - 728

[4] THE ANTIPROLIFERATIVE PROPERTIES OF TAMOXIFEN AND PHENOTHIAZINES MAY BE MEDIATED BY A UNIQUE HISTAMINE-RECEPTOR (QUESTIONABLE-H-3) DISTINCT FROM THE CALMODULIN-BINDING SITE [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 18 (01) : 21 - 23

[5] BRANDES LJ, 1987, CANCER RES, V47, P4025

[6] EVIDENCE THAT THE ANTIESTROGEN BINDING-SITE IS A HISTAMINE OR HISTAMINE-LIKE RECEPTOR [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 126 (02) : 905 - 910

[7] NEW EVIDENCE THAT THE ANTIESTROGEN BINDING-SITE MAY BE A NOVEL GROWTH-PROMOTING HISTAMINE-RECEPTOR (QUESTIONABLE-H-3) WHICH MEDIATES THE ANTIESTROGENIC AND ANTIPROLIFERATIVE EFFECTS OF TAMOXIFEN [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 134 (02) : 601 - 608

[8] SEPARABLE ASSEMBLY OF PLATELET PSEUDOPODAL AND CONTRACTILE CYTOSKELETONS [J]. CELL, 1982, 30 (02) : 385 - 393

[9] COMPARING BINDING OF HISTAMINE AND H2-ANTAGONIST WITH THEIR EFFECTS ON GASTRIC-ACID SECRETION [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1987, 923 (02) : 315 - 322

[10] GERRARD JM, 1989, BLOOD, V74, P2405

[1] BRANDES LJ, 1988, CANCER RES, V48, P3954

[2] A DIPHENYLMETHANE DERIVATIVE SELECTIVE FOR THE ANTI-ESTROGEN BINDING-SITE MAY HELP DEFINE ITS BIOLOGICAL ROLE [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 124 (01) : 244 - 249

[3] A DIPHENYLMETHANE DERIVATIVE SPECIFIC FOR THE ANTIESTROGEN BINDING-SITE FOUND IN RAT-LIVER MICROSOMES [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 123 (02) : 724 - 728

[4] THE ANTIPROLIFERATIVE PROPERTIES OF TAMOXIFEN AND PHENOTHIAZINES MAY BE MEDIATED BY A UNIQUE HISTAMINE-RECEPTOR (QUESTIONABLE-H-3) DISTINCT FROM THE CALMODULIN-BINDING SITE [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 18 (01) : 21 - 23

[5] BRANDES LJ, 1987, CANCER RES, V47, P4025

[6] EVIDENCE THAT THE ANTIESTROGEN BINDING-SITE IS A HISTAMINE OR HISTAMINE-LIKE RECEPTOR [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 126 (02) : 905 - 910

[7] NEW EVIDENCE THAT THE ANTIESTROGEN BINDING-SITE MAY BE A NOVEL GROWTH-PROMOTING HISTAMINE-RECEPTOR (QUESTIONABLE-H-3) WHICH MEDIATES THE ANTIESTROGENIC AND ANTIPROLIFERATIVE EFFECTS OF TAMOXIFEN [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 134 (02) : 601 - 608

[8] SEPARABLE ASSEMBLY OF PLATELET PSEUDOPODAL AND CONTRACTILE CYTOSKELETONS [J]. CELL, 1982, 30 (02) : 385 - 393

[9] COMPARING BINDING OF HISTAMINE AND H2-ANTAGONIST WITH THEIR EFFECTS ON GASTRIC-ACID SECRETION [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1987, 923 (02) : 315 - 322

[10] GERRARD JM, 1989, BLOOD, V74, P2405